{"data":[{"id":"a5d38c30-1354-4ae1-9502-4026267d01bc","type":"activities","attributes":{"prov:wasGeneratedBy":"https://api.datacite.org/activities/a5d38c30-1354-4ae1-9502-4026267d01bc","prov:generatedAtTime":"2026-05-28T13:35:14Z","prov:wasDerivedFrom":"https://doi.org/10.71760/ukllc-dataset-00379-02","prov:wasAttributedTo":"https://api.datacite.org/repositories/vhfs.ukllc","action":"update","version":3,"changes":{"url":["https://guidebook.ukllc.ac.uk/docs/linked_health_data/nhs_england/covid%20datasets/ielisa/ielisa","https://guidebook.ukllc.ac.uk/docs/linked_health_data/nhs_england/covid_datasets/ielisa/ielisa"]}}},{"id":"c6100fc8-b01a-4e4d-aa67-0e7d5937d0d3","type":"activities","attributes":{"prov:wasGeneratedBy":"https://api.datacite.org/activities/c6100fc8-b01a-4e4d-aa67-0e7d5937d0d3","prov:generatedAtTime":"2025-07-28T17:27:52.690Z","prov:wasDerivedFrom":"https://doi.org/10.71760/ukllc-dataset-00379-02","prov:wasAttributedTo":"https://api.datacite.org/repositories/vhfs.ukllc","action":"update","version":2,"changes":{"aasm_state":["draft","findable"],"schema_version":[null,"http://datacite.org/schema/kernel-4"]}}},{"id":"cc2d72b0-30fc-4a28-898a-b2674bd5fa76","type":"activities","attributes":{"prov:wasGeneratedBy":"https://api.datacite.org/activities/cc2d72b0-30fc-4a28-898a-b2674bd5fa76","prov:generatedAtTime":"2025-07-28T17:23:21.975Z","prov:wasDerivedFrom":"https://doi.org/10.71760/ukllc-dataset-00379-02","prov:wasAttributedTo":"https://api.datacite.org/repositories/vhfs.ukllc","action":"create","version":1,"changes":{"doi":"10.71760/UKLLC-DATASET-00379-02","url":"https://guidebook.ukllc.ac.uk/docs/linked_health_data/nhs_england/covid%20datasets/ielisa/ielisa","dates":[{"date":"2020-09/","dateType":"Collected"},{"date":"2023-04-13","dateType":"Issued"}],"sizes":null,"types":{"ris":"DATA","bibtex":"misc","citeproc":"dataset","schemaOrg":"Dataset","resourceTypeGeneral":"Dataset"},"reason":null,"source":"api","titles":[{"title":"NHS England: Enzyme-Linked Immunosorbent Assay"},{"title":"NHSE_IELISA","titleType":"AlternativeTitle"}],"formats":null,"creators":[{"name":"Data Services, NHS England (NHSE)"}],"language":"en","subjects":[{}],"container":null,"publisher":"UK Longitudinal Linkage Collaboration (UK LLC)","aasm_state":"draft","regenerate":true,"content_url":null,"identifiers":[{"identifier":"NHSE","identifierType":"UKLLC series"}],"rights_list":null,"contributors":[{"name":"Data Services, NHS England (NHSE)","contributorType":"DataCurator"}],"descriptions":[{"lang":"English","description":"This dataset is better known as the COVID-19 UK Non-hospital Antibody Testing Results dataset. It covers UK-wide Pillar 3 finger prick testing for antibodies in people who have had a confirmed COVID-19 infection. Data collected include demographic and diagnostic information.","descriptionType":"Abstract"}],"landing_page":null,"version_info":"2","geo_locations":null,"only_validate":false,"related_items":null,"schema_version":null,"should_validate":false,"publication_year":2023,"funding_references":null,"related_identifiers":null}}}],"meta":{"total":3,"totalPages":1,"page":1},"links":{"self":"https://api.datacite.org/dois/10.71760/ukllc-dataset-00379-02/activities"}}